Results 91 to 100 of about 39,159 (175)

Probing rate of YMDD motif mutant in lamivudine treatment of Iranian patients with chronic hepatitis B virus infection

Asian Journal of Transfusion Science, 2011
Background: Lamivudine is an analog nucleoside used for the treatment of chronic hepatitis B virus (CHV) infection. Studies showed that prolonged therapy could induce lamivudine resistance hepatitis B virus (HBV) variants (YMDD motif). In this study, the
Ghandehari Freshte, Pourazar Abasali, Zadeh Mehrnaz, Tajedin Nahid   +3 more
doaj  

Lamivudine-induced muscle mitochondrial toxicity

, 2002
Lamivudine-induced muscle mitochondrial ...
Ojetti, Veronica, Santoliquido, Angelo, Gasbarrini, Antonio, Gentiloni Silveri, Nicolo', Agnes, Salvatore, Pola, Paolo, Migneco, Alessio, Flore, Roberto Antonio, De Martini, Demetrio   +8 more
core  

Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection

HIV/AIDS: Research and Palliative Care, 2019
Francis J Zamora,1,2 Ellen Dowers,2 Faiza Yasin,3 Onyema Ogbuagu3 1Department of Pharmacy Services, Broward Health Medical Center, Fort Lauderdale, FL, USA; 2Department of Pharmacy Services, Yale-New Haven Hospital, New Haven, CT, USA; 3Section of ...
Zamora FJ, Dowers E, Yasin F, Ogbuagu O
doaj  

Entecavir for Treatment of Lamivudine-Refractory, HBeAg-Positive Chronic Hepatitis B

, 2006
Background & Aims: Lamivudine treatment is associated with frequent development of resistant hepatitis B virus (HBV) and loss of treatment benefit. In preclinical and phase II studies, entecavir demonstrated potent antiviral activity against lamivudine ...
Boron–Kaczmarska, Anna, Cianciara, Janusz, Kreter, Bruce, Martin, Paul, Liaw, Yun–Fan, Cross, Anne, Hindes, Robert, AI463026 BEHoLD Study Group, Sherman, Morris, Denisky, Gail, Yurdaydin, Cihan, Goodman, Zachary, Sollano, Jose, Colonno, Richard, Silva, Marcelo   +14 more
core   +1 more source

Lamivudine therapy for chronic hepatitis B

, 2010
Lamivudine was introduced as an antiviral for chronic hepatitis B over a decade ago. Its role in the management of CHB has been constantly changing. Lamivudine has proven benefit in both hepatitis B e antigen‐positive and ‐negative patients.
Fung, J, Yuen, RMF, Lai, CL, Seto, WK
core  

Salts of the anti-HIV drug lamivudine with phthalic and salicylic acids

, 2012
Salts of the anti-HIV drug lamivudine, with phthalic acid and salicylic acid as counterions, were investigated in this study. Neither the packing of the (lamivudine)(+)(phthalic acid)(-) ion pairs nor the conformation of the lamivudine moiety itself were
da Silva, Cameron Capeletti, Campos de Melo, Ariane Carla, Coelho, Renan Rezende, Landre Rosa, Iara Maria, Ellena, Javier, Martins, Felipe Terra, Cirqueira, Marilia de Lima   +6 more
core   +1 more source

The duration of lamivudine therapy for chronic hepatitis b: Cessation vs. continuation of treatment after HBeAg seroconversion

, 2009
OBJECTIVES: The aim of this study was to compare the virological and biochemical relapse rates in Asian chronic hepatitis B patients with lamivudine-induced hepatitis B e antigen (HBeAg) seroconversion, between those who stopped therapy after HBeAg ...
Yuen, J, Tanaka, Y, Fung, J, Lai, CL, Wong, DKH, Mizokami, M, Yuen, MF   +6 more
core   +1 more source

Incidence and determinants of excessive weight gain in people living with HIV initiating tenofovir, lamivudine, and dolutegravir-based therapy: a multicenter retrospective study in northwest Ethiopia

Frontiers in Pharmacology
BackgroundThe incidence and nature of excessive weight gain associated with antiretroviral treatment using tenofovir, lamivudine, and dolutegravir based regimens among patients living with human immunodeficiency virus has not been properly examined in ...
Gashaw Sisay Chanie, Wagaye Atalay, Tirsit Ketsela Zeleke, Zemenu Wube Bayleyegn, Yonas Sisay Aragie, Gizachew Kassahun Bizuneh, Mihret Melese, Rahel Belete Abebe   +7 more
doaj   +1 more source

Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa

Brazilian Journal of Infectious Diseases
The coinfection of HIV and hepatitis B virus (HBV) and their vertical transmission constitute a public health problem in sub-Saharan countries of Africa.
Denise Ilboudo, Jacques Simpore, Djeneba Ouermi, Cyrille Bisseye, Tani Sagna, Silvia Odolini, Fabio Buelli, Virginio Pietra, Salvatore Pignatelli, Charlemagne Gnoula, Jean-Baptiste Nikiema, Salvatore Musumeci   +11 more
doaj   +1 more source

Immunovirological treatment out- comes after 2 years of antiretroviral therapy in children living with the human immune deficiency virus in Lagos Nigeria

Nigerian Journal of Paediatrics
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O, Akindele AJ, Akanmu AS, Adeyemi OO   +3 more
doaj